Early MRD detection can change the trajectory of post-HCT outcomes. Learn more about LabPMM’s fast, sensitive MRD assays. https://t.co/3c9WvEIBoR #AML #BoneMarrowTransplant #MRDMatters #PrecisionDiagnostics #JAMAOncology

Even more exciting posters to come tomorrow at #AMPath2025!!

Thank you to everyone who stopped by poster #TT082: "The LymphoTrack Flex Assay: A High-Throughput NGS Assay for the Assessment of Clonality in Lymphoproliferative Diseases.” Presented by Angelo Arias, PhD. At the #AMPath2025 poster sessions today.

We’re excited to be on the show floor at #AMPath2025! Stop by booth #821 to connect with the Invivoscribe team and learn how our innovative testing solutions are advancing precision diagnostics worldwide. #AML #Invivoscribe #MRD #Clonality

We’re here at #AMPath2025! Join us today at 2 p.m. for our workshop on optimizing NGS for MRD detection using cfDNA in #NHL and exploring the prognostic significance of NGS-based MRD detection in #AML. Don’t miss it!

Your lab deserves flexibility. Invivoscribe’s LymphoTrack® Assays are now supported on Illumina MiSeq i100, NextSeq & Complete Genomics DNBSEQ-G99. Confident MRD monitoring, without compromise. Learn more: https://t.co/H2hX0gjvDv #MRD #NGS #Lymphotrack #clonality #AMPath2025

Stop by poster #H019 at #AMPath2025 to hear Lauren Petersen, PhD. present “Best Practices for the Detection, Interpretation, and Reporting of In Cis Variants in AML.” Join us on November 15 from 9:15–10:15 a.m. to catch this informative presentation on in cis variants in #AML.

Stop by booth #821 to learn more about our solutions for non-invasive disease monitoring: https://t.co/UPURJ1YGf8 #MRD #invivoscribe

Join us at #AMPath2025 for an #Invivoscribe workshop presented by Dr. Xian and Dr. Dillon on the importance of molecular markers for measurable residual disease in lymphoma and leukemia.

Stop by poster #H029 presented by Paulina Gomez at the #AMPath2025 poster session on November 15 from 9:15-10:15 AM to learn about our AML testing services. Visit https://t.co/IsEc1n3LjS to learn more about MyAML and MyMRD. #LabPMM #AML #GenePanels #MRD

The NGS-based NPM1 MRD Assay and Software are now available globally. Questions? Reach out to us today at https://t.co/HuSNj5jpee or read more about the importance of measurable residual disease detection at https://t.co/jxwMrvLwBQ #NPM1 #MRD #AML #invivoscribe

MRD assessment prior to alloHCT can help optimize pre- and post-transplant strategies to improve patient outcomes. Stop by booth #821 at #AMPath2025 to discuss LabPMM’s highly-sensitive #AML #MRD NGS and flow testing services. #FLT3ITD #NPM1

Stop by to explore the data and discuss our latest developments in precision diagnostics. #Clonality #MRD #Invivoscribe

We are counting down the days to #AMPath2025! On November 15 from 9:15-10:15 AM Check out: #TT071: “Performance Comparison of Invivoscribe’s B-cell and T-cell LymphoTrack® Assays between MiSeq and MiSeq i100.” Presented by Jonathan Guterres.

Stop by the poster session on November 15 from 9:15-10:15 AM to learn how Invivoscribe supports precision diagnostics worldwide.

Heading to #AMPath2025? Don’t miss our poster presentation! #H049: “KMT2A Fusion Detection for Measurable Residual Disease in Acute Myeloid Leukemia Using a Novel Multiplex Digital PCR Assay.” Presented by Matthew Holman.

Stop by booth #821 to chat with us about our MRD kits, software and services: https://t.co/UPURJ1YGf8 #MRD #invivoscribe

We have the pleasure of hosting Dr. Xian and Dr. Dillon at #Invivoscribe’s #AMPath2025 Workshop. These KOLs will discuss optimizing NGS for MRD detection using cfDNA in #NHL and the prognostic significance of NGS-based MRD detection in #AML.

We are pleased to announce that our experts will be sharing multiple posters at AMP 2025 this year in Boston! Swing by the poster sessions on November 14 and 15 to learn more about our best-in-class hematology-oncology products & services! #MRD #Clonality #AMPath2025 #AML #NGS

According to Levis et al. (Blood, 2025), MRD positivity after induction or before HCT is the strongest predictor of relapse. Learn more about LabPMM’s fast, sensitive MRD assays. https://t.co/jueHWEQI4t #AML #MRDtesting #TransplantOutcomes #LeukemiaResearch #LabPMM